Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Healius Limited ( (AU:HLS) ) has issued an update.
Healius Limited has announced that it will release its financial results for the first half of the 2026 financial year on 18 February 2026, followed by a webcast briefing for analysts and investors. The company will host an online presentation at 10:30 a.m. AEST on the same day, with participants able to join via a dedicated webcast and teleconference, including an opportunity to submit questions, underscoring Healius’s ongoing engagement and transparency with the investment community.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.95 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is an Australian-listed healthcare company that operates in the medical services industry, providing pathology, diagnostic imaging, and related health services to patients and healthcare providers across Australia.
Average Trading Volume: 2,075,543
Technical Sentiment Signal: Sell
Current Market Cap: A$689.8M
Learn more about HLS stock on TipRanks’ Stock Analysis page.